








anticancer agent for acute promyelocyticleukemia仏PL）．In the present study，We
examinedtheanticancereffectsofAs203atlowconcentrationわ．25～2．OFLM）ontwohunan
leukemia／lymphomacelllines，HL－60andRL，invitro．WefoundthatAs203inhibitedthe
growth ofHL－60andRL similar to the reportedAPL cellline，NB4・Typicalapoptosis
was observedin morphologlCalstudy and DNAfragmentation assay，aS Wellas a cell
cycle arrest at subGl・To address the mechanism ofAs203－induced apoptosis，We also
examinedtheeffectofAs2030ntheCD95／CD95Lpathwayandbc1－2proteinexpression．
The results showed that the CD95／CD95L expressions were upregulated；meanWhile，
caspase8and caspase3were activated．However，the bcト2protein expression was
downregulated．Using antilニD95monoclonal antibody to block the CD95　pathway，
As203－inducedapoptosiswasameliorated．ThesedatasuggestthatinHL－60andRLcell





promyelocyticleukemia　仏．pL），eVenin patients relapsed after all－tranS retinoic acid




lung canCerll），human OVarian　CarCinoma12），and human breast cancer13）・The molecular
mechanismofAs203treatmentiscontroversial．ThemodulationofPML／RARαfusionprotein





Current evidence suggests that the mechanism ofsome anticancer agentsinvolves the
activationofthe CD95／CD95Lpathway15L18）．In thepresent study，Weinvestigatedanticancer
molecular mechanism of As2030n tWOleukemia／lymphoma celllines，HL－60and RL，and
（114） As203inducesapoptosisinHL－60andRL





































































These results showed that As203　WaS a pOtentinhibitor of the proliferation of
leukemia／1ymphomacells．
2．MorphologicalchangeSandcellcyclearreSt





































































































































































































































































































isinvoIvedin theactivationoftheCD95／CD95Lpathwaywhichisakey signalpathway to




hypothesis，We determined activities ofcaspase8and caspase3，Which are downstream of
CD95／CD95L．Theresultsshowedthatcaspase8andcaspase3wereactivatedbyAs203．Itis





anti一｛D95　MoAb．As203－induced apoptosis was suppressed．From this resultit was
demonstrated that the CD95／CD95L pathwayis animportant molecular mechanismin
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